234 related articles for article (PubMed ID: 29575033)
21. Dystonia and ataxia progression in spinocerebellar ataxias.
Kuo PH; Gan SR; Wang J; Lo RY; Figueroa KP; Tomishon D; Pulst SM; Perlman S; Wilmot G; Gomez CM; Schmahmann JD; Paulson H; Shakkottai VG; Ying SH; Zesiewicz T; Bushara K; Geschwind MD; Xia G; Subramony SH; Ashizawa T; Kuo SH
Parkinsonism Relat Disord; 2017 Dec; 45():75-80. PubMed ID: 29089256
[TBL] [Abstract][Full Text] [Related]
22. Dopamine transporter positron emission tomography in spinocerebellar ataxias type 1, 2, 3, and 6.
Wüllner U; Reimold M; Abele M; Bürk K; Minnerop M; Dohmen BM; Machulla HJ; Bares R; Klockgether T
Arch Neurol; 2005 Aug; 62(8):1280-5. PubMed ID: 16087769
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study.
Ashizawa T; Figueroa KP; Perlman SL; Gomez CM; Wilmot GR; Schmahmann JD; Ying SH; Zesiewicz TA; Paulson HL; Shakkottai VG; Bushara KO; Kuo SH; Geschwind MD; Xia G; Mazzoni P; Krischer JP; Cuthbertson D; Holbert AR; Ferguson JH; Pulst SM; Subramony SH
Orphanet J Rare Dis; 2013 Nov; 8():177. PubMed ID: 24225362
[TBL] [Abstract][Full Text] [Related]
24. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms.
Schmitz-Hübsch T; Coudert M; Bauer P; Giunti P; Globas C; Baliko L; Filla A; Mariotti C; Rakowicz M; Charles P; Ribai P; Szymanski S; Infante J; van de Warrenburg BP; Dürr A; Timmann D; Boesch S; Fancellu R; Rola R; Depondt C; Schöls L; Zdienicka E; Kang JS; Döhlinger S; Kremer B; Stephenson DA; Melegh B; Pandolfo M; di Donato S; du Montcel ST; Klockgether T
Neurology; 2008 Sep; 71(13):982-9. PubMed ID: 18685131
[TBL] [Abstract][Full Text] [Related]
25. Autosomal dominant cerebellar ataxias: Imaging biomarkers with high effect sizes.
Adanyeguh IM; Perlbarg V; Henry PG; Rinaldi D; Petit E; Valabregue R; Brice A; Durr A; Mochel F
Neuroimage Clin; 2018; 19():858-867. PubMed ID: 29922574
[TBL] [Abstract][Full Text] [Related]
26. The Initial Symptom and Motor Progression in Spinocerebellar Ataxias.
Luo L; Wang J; Lo RY; Figueroa KP; Pulst SM; Kuo PH; Perlman S; Wilmot G; Gomez CM; Schmahmann J; Paulson H; Shakkottai VG; Ying SH; Zesiewicz T; Bushara K; Geschwind M; Xia G; Subramony SH; Ashizawa T; Kuo SH
Cerebellum; 2017 Jun; 16(3):615-622. PubMed ID: 27848087
[TBL] [Abstract][Full Text] [Related]
27. A longitudinal investigation into cognition and disease progression in spinocerebellar ataxia types 1, 2, 3, 6, and 7.
Moriarty A; Cook A; Hunt H; Adams ME; Cipolotti L; Giunti P
Orphanet J Rare Dis; 2016 Jun; 11(1):82. PubMed ID: 27333979
[TBL] [Abstract][Full Text] [Related]
28. Analysis and hierarchical clustering of infratentorial morphological MRI identifies SCAs phenogroups.
Zhao J; Zeng W; Huang X; Hu M; Yuan K; Wu C; Qiu H; Chu J
J Neurol; 2023 Sep; 270(9):4466-4477. PubMed ID: 37291395
[TBL] [Abstract][Full Text] [Related]
29. Noninvasive detection of presymptomatic and progressive neurodegeneration in a mouse model of spinocerebellar ataxia type 1.
Oz G; Nelson CD; Koski DM; Henry PG; Marjanska M; Deelchand DK; Shanley R; Eberly LE; Orr HT; Clark HB
J Neurosci; 2010 Mar; 30(10):3831-8. PubMed ID: 20220018
[TBL] [Abstract][Full Text] [Related]
30. Long-term evolution of patient-reported outcome measures in spinocerebellar ataxias.
Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Sarro L; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Nachbauer W; Kang JS; Pandolfo M; Schulz JB; Melac AT; Diallo A; Klockgether T
J Neurol; 2018 Sep; 265(9):2040-2051. PubMed ID: 29959555
[TBL] [Abstract][Full Text] [Related]
31. Neurochemical Differences in Spinocerebellar Ataxia Type 14 and 1.
Grosch AS; Rinnenthal JL; Rönnefarth M; Lux S; Scheel M; Endres M; Brandt AU; Paul F; Schmitz-Hübsch T; Minnerop M; Doss S
Cerebellum; 2021 Apr; 20(2):169-178. PubMed ID: 33063293
[TBL] [Abstract][Full Text] [Related]
32. Disease progression of spinocerebellar ataxia types 1, 2, 3 and 6 before and after ataxia onset.
Jacobi H; Schaprian T; Schmitz-Hübsch T; Schmid M; Klockgether T;
Ann Clin Transl Neurol; 2023 Oct; 10(10):1833-1843. PubMed ID: 37592453
[TBL] [Abstract][Full Text] [Related]
33. Clinical and neuroradiological features of patients with spinocerebellar ataxias from Korean kindreds.
Bang OY; Huh K; Lee PH; Kim HJ
Arch Neurol; 2003 Nov; 60(11):1566-74. PubMed ID: 14623729
[TBL] [Abstract][Full Text] [Related]
34. Eye Movement Abnormalities Are Ubiquitous in the Spinocerebellar Ataxias.
Stephen CD; Schmahmann JD
Cerebellum; 2019 Dec; 18(6):1130-1136. PubMed ID: 31175630
[TBL] [Abstract][Full Text] [Related]
35. Postural Tremor and Ataxia Progression in Spinocerebellar Ataxias.
Gan SR; Wang J; Figueroa KP; Pulst SM; Tomishon D; Lee D; Perlman S; Wilmot G; Gomez CM; Schmahmann J; Paulson H; Shakkottai VG; Ying SH; Zesiewicz T; Bushara K; Geschwind MD; Xia G; Subramony SH; Ashizawa T; Kuo SH
Tremor Other Hyperkinet Mov (N Y); 2017; 7():492. PubMed ID: 29057148
[TBL] [Abstract][Full Text] [Related]
36. Natural history of most common spinocerebellar ataxia: a systematic review and meta-analysis.
Diallo A; Jacobi H; Tezenas du Montcel S; Klockgether T
J Neurol; 2021 Aug; 268(8):2749-2756. PubMed ID: 32266540
[TBL] [Abstract][Full Text] [Related]
37. Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6.
Reetz K; Costa AS; Mirzazade S; Lehmann A; Juzek A; Rakowicz M; Boguslawska R; Schöls L; Linnemann C; Mariotti C; Grisoli M; Dürr A; van de Warrenburg BP; Timmann D; Pandolfo M; Bauer P; Jacobi H; Hauser TK; Klockgether T; Schulz JB;
Brain; 2013 Mar; 136(Pt 3):905-17. PubMed ID: 23423669
[TBL] [Abstract][Full Text] [Related]
38. Central auditory processing in patients with spinocerebellar ataxia.
Zeigelboim BS; de Carvalho HA; Teive HA; Liberalesso PB; Jurkiewicz AL; da Silva Abdulmassih EM; Marques JM; Cordeiro ML
Hear Res; 2015 Sep; 327():235-44. PubMed ID: 26183435
[TBL] [Abstract][Full Text] [Related]
39. Cognitive-affective manifestations since premanifest phases of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.
Bolzan G; Müller Eyng ME; Leotti VB; Saraiva-Pereira ML; Jardim LB
Cortex; 2024 Feb; 171():370-382. PubMed ID: 38091940
[TBL] [Abstract][Full Text] [Related]
40. Spinocerebellar ataxias in mainland China: an updated genetic analysis among a large cohort of familial and sporadic cases.
Wang J; Shen L; Lei L; Xu Q; Zhou J; Liu Y; Guan W; Pan Q; Xia K; Tang B; Jiang H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):482-9. PubMed ID: 21743138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
